TP53 mutational status indicates distinct outcomes in SHH-MBs: TP53 wild type tumors are more frequent among adults and young children and are related to a favorable prognosis, while TP53 mutation tumors are common among older children and are linked to adverse outcomes (10). This evidence concerns the gene TP53 and Mobius syndrome.